Flow cytometric immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 1 using insoluble precursor forms of recombinant polyproteins as carriers and antigens

Journal of Clinical Microbiology

Volumn 34, Issue 6, 1996, Pages 1412-1419

  Hu, Yu Wen ^a   Birch, Paul ^a   Balaskas, Evan ^a   Zeibdawi, Abed ^a   Scalia, Vito ^a   Thériault Valin, Susan Anne ^a   Gill, Peter ^a   Aye, Maung T ^a  

^a Canadian Red Cross Society   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHIMERIC PROTEIN; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SEROCONVERSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INSECTA; UNIDENTIFIED BACULOVIRUS;

EID: 0029894615     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.6.1412-1419.1996     Document Type: Article

References (29)

1. Benjouad, A., J.-C. Gluckman, L. Montagnier, and E. Bahraoui. 1993. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160. J. Virol. 67:1693-1697.
2. Borkowsky, W., K. Krasinski, H. Pollack, W. Hoover, A. Kaul, and T. Ilmet-Moore. 1992. Early diagnosis of human immunodeficiency virus infection in children >6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J. Infect. Dis. 166:616-619.
3. Busch, M. P. 1994. HIV and blood transfusions: focus on seroconversion. 23rd Congress of the International Society of Blood Transfusion. Vox Sang. 67(Suppl. 3):13-18.
4. Farmer, J, L., R. G. Hampton, and E. Boots. 1989 Flow cytometric assays for monitoring production of recombinant HIV-1 gp160 insect cells infected with a baculovirus expression vector. J. Virol. Methods 26:279-290.
5. Gallarda, J. L., D. R. Henrard, D. Liu, S. Harrington, S. L. Stramer, J. K. Valinsky, and P. Wu. 1992. Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J. Clin. Microhiol. 30: 2379-2384.
6. Hu, Y.-W., and C. Y. Kang. 1991. Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products. Proc. Natl. Acad. Sci. USA 88:4596-4600.
7. Kashala, O., K. kayembe, P. Kanki, P. Mukeba, M. Diese, M. Kalengayi, K.-W. Izzia, and M. Essex. 1993. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels. AIDS Res. Hum. Retroviruses 9:251-258.
8. Khalife, J., B. Guy, M. Capron, M.-P. Kieny, J.-C. Ameisen, L. Montagnier, J.-P. Lecocq, and A. Capron. 1988. Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res. Hum. Retroviruses 4:3-9.
9. Kidd, I. M., and V. C. Emery. 1993. The use of baculoviruses as expression vectors. Appl. Biochem. Biotechnol. 42:137-159.
10. Laerum, O. D., and R. Bjerknes. 1992. Flow cytometry in hematology. Academic Press. London.
11. Longobardi Givan, A. 1992. Flow cytometry: first principles. Wiley-Liss Inc., New York.
12. Luo, L., L. Yan, P. M. Cannon, K. Sunyoung, and C. Y. Kang. 1992. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc. Natl. Acad. Sci. USA 89:10527-10531.
13. Martin, R., J. R. George, M. Hanson, J. Pearson, R. Turnicky, and J. Wethers. 1993. Report of the Eighth Annual Conference on Human Retrovirus Testing. Association of State and Territorial Public Health Laboratory Directors.
14. Mayo, D. J., A. M. Rose, S. E. Matchett, P. A. Hoppe, J. M. Solomon, and K. K. McCurdy. 1991. Screening potential blood donors at risk for human immunodeficiency virus. Transfusion 31:466-474.
15. Nair, B. C., G. Ford, V. S. Kalyanaraman, M. Zafari, C. Fang, and M. G. Sarngadharan. 1994. Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies. J. Clin. Microbiol. 32:1449-1456.
16. gag and is incorporated into viruslike particles. J. Virol. 66:6304-6313.
17. Petersen, L. R., G. A. Satten, R. Dodd, M. Busch, S. Kleinman, A. Grindon, B. Lenes, and the HIV Seroconversion Study Group, 1994. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 34:283-289.
18. Race, E. M., K. M. Ramsey, H. L. Lucia, and M. W. Cloyd. 1991. Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology. Virology 184: 716-722.
19. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanolf, S. R. Petteway, Jr., M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
20. Reagan, K. J., C. C. Lile, Y. Devash, J. Turner, Y.-W. Hu, and C. Y. Rang. 1990. Use of HIV-1 pol gene precursor to detect HIV-1 and HIV-2. Lancet 335:236.
21. Simmonds, P., D. Beatson, R. J. G. Cuthbert, H. Watson, B. Reynolds, J. F. Peutherer, J. V. Parry, C. A. Ludlam, and C. M. Steel. 1991. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338:1159-1163.
22. Simon, F., J. M. Pépin, and F. Brun-Vezinet. 1992. Reliability of Western blotting for the confirmation of HIV-1 seroconversion. Lancet 340:1541-1542.
23. Sinicco, A., R. Fora, M. Sciandra, A. Lucchini, P. Caramello, and P. Gioannin. 1993. Risk of developing AIDS after primary acute HIV-1 infection. J. Acquired Immune Defic. Syndr. 6:575-581.
24. Sligh, J. M., B. S. Stanford, T. Roodman, and C. C. Tsai. 1989. Flow cytometric indirect immunofluorescence assay with high sensitivity and specificity for detection of antibodies to human immunodeficiency virus (HIV). Am. J. Clin. Pathol. 91:210-214.
25. Takehara, K., D. Ireland, and D. H. L. Bishop. 1988. Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors. J. Gen. Virol. 69:2763-2777.
26. Wagner, R., H. Fliessbach, G. Wanner, M. Motz, M. Niedrig, G. Deby, A. von Brunn, and H. Wolf. 1992. Studies on processing particle formation and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine. Arch. Virol. 127:117-137.
27. Willerford, D. M., J. J. Bwayo, M. Hensel, W. Emonyi, F. A. Plummer, E. N. Ngugi, N. Nagelkerke, W. M. Gallatin, and J. Kreiss. 1993. Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi. J. Infect. Dis. 167:1414-1417.
28. Zaaijer, H. L., P. V. Exel-Oehlers, T. Kraaijeveld, E. Altena, and P. N. Lelie. 1992. Early detection of antibodies to HIV-1 by third generation assays. Lancet 340:770-772.
29. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.